Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2019-04-30 M&A Activity
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
타법인주식및출자증권처분결정
M&A Activity Classification · 95% confidence The document is a regulatory filing from a Korean company (IntroMedic) regarding the decision to dispose of shares in another corporation (Hyunjin Materials). This type of disclosure, which details the disposal of assets, the purpose of the transaction, and the board's resolution, is a standard corporate regulatory announcement. Since it does not fit into specific categories like M&A (which usually implies a merger or acquisition of the company itself) or share buybacks (which would be POS), it falls under the general regulatory filing category.
2019-04-30 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'IntroMedic', detailing the date, location, and agenda items (such as articles of incorporation changes and director/auditor appointments). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of upcoming votes. Given the specific category list, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting and its agenda.
2019-04-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of an Extraordinary General Meeting. It does not contain full financial statements or meeting materials, but rather serves as a formal notice of a corporate action. Since it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2019-04-19 Korean
[첨부추가]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party capital increase (유상증자결정). It details the issuance of new shares, the purpose of the funds, the pricing basis, and the identity of the third-party investor (Intromedic). This type of filing is a formal regulatory disclosure concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2019-04-19 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a lawsuit ('소송등의제기ㆍ신청') filed against the company Intromedic. It details the plaintiff, the claim amount, the court, and the company's planned legal response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant litigation.
2019-04-15 Korean
사업보고서 (2018.12)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Intromedic Co., Ltd. for the fiscal year ending December 31, 2018. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This is a comprehensive annual financial report, which falls under the 'Interim / Quarterly Report' (IR) category in the provided schema, as it contains full financial statements and analysis for a specific period, distinct from a 10-K (which is typically a US-specific regulatory filing). FY 2018
2019-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.